State Street’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
106,678
-414,528
| -80% | -$481K | ﹤0.01% | 3938 |
|
|
2025
Q1 | $573K | Sell |
521,206
-4,600
| -0.9% | -$5.06K | ﹤0.01% | 3564 |
|
|
2024
Q4 | $904K | Buy |
525,806
+9,400
| +2% | +$16.2K | ﹤0.01% | 3510 |
|
|
2024
Q3 | $1.28M | Buy |
516,406
+79,841
| +18% | +$198K | ﹤0.01% | 3439 |
|
|
2024
Q2 | $1.06M | Buy |
436,565
+354,787
| +434% | +$859K | ﹤0.01% | 3466 |
|
|
2024
Q1 | $331K | Sell |
81,778
-3,300
| -4% | -$13.4K | ﹤0.01% | 3750 |
|
|
2023
Q4 | $327K | Buy |
85,078
+25,300
| +42% | +$97.2K | ﹤0.01% | 3755 |
|
|
2023
Q3 | $248K | Hold |
59,778
| – | – | ﹤0.01% | 3869 |
|
|
2023
Q2 | $288K | Hold |
59,778
| – | – | ﹤0.01% | 3889 |
|
|
2023
Q1 | $243K | Hold |
59,778
| – | – | ﹤0.01% | 4003 |
|
|
2022
Q4 | $323K | Buy |
59,778
+12,400
| +26% | +$67K | ﹤0.01% | 3923 |
|
|
2022
Q3 | $475K | Buy |
47,378
+12,900
| +37% | +$129K | ﹤0.01% | 3799 |
|
|
2022
Q2 | $162K | Sell |
34,478
-150,380
| -81% | -$707K | ﹤0.01% | 4299 |
|
|
2022
Q1 | $723K | Buy |
184,858
+73,495
| +66% | +$287K | ﹤0.01% | 3908 |
|
|
2021
Q4 | $753K | Buy |
111,363
+11,588
| +12% | +$78.4K | ﹤0.01% | 3880 |
|
|
2021
Q3 | $1.48M | Buy |
+99,775
| New | +$1.48M | ﹤0.01% | 3696 |
|